Osteoblast inhibition by chemokine cytokine ligand3 in myeloma-induced bone disease

Cancer Cell International

Volumn 14, Issue 1, 2014, Pages

  Fu, Rong ^a   Liu, Hui ^a   Zhao, Sijie ^a   Wang, Yihao ^a   Li, Lijuan ^a   Gao, Shan ^a   Ruan, Erbao ^a   Wang, Guojin ^a   Wang, Huaquan ^a   Song, Jia ^a   Shao, Zonghong ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Chemokine cytokine ligand 3; Myeloma bone disease; Osteoblast; Osterix; Runx2

Indexed keywords

CXCL3 CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; OSTEOCALCIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2;

ADULT; AGED; ARTICLE; BONE DISEASE; CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HISTOCHEMISTRY; HUMAN; IN VITRO STUDY; MALE; MYELOMA; MYELOMA BONE DISEASE; OSTEOBLAST; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84924044905     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/s12935-014-0132-6     Document Type: Article

References (31)

1. Taube T, Beneton MNC, McCloskey EV, Rogers S, Greaves M, Kanis JA: Abnormal bone remodeling in patients with myelomatosis and normal biochemical indices of bone resorption[J]. Eur J Haematol 1992, 49(4):192-198.
2. Roodman GD, Choi SJ: MIP-1 Alpha and Myeloma Bone Disease. In The Biology of Skeletal Metastases. In Cancer Treatment and Research Volume 118. 2nd edition. Edited by Keller ET, Leland WK C. US: Springer; 2004:83-100.
3. Terpos E, Politou M, Szydlo R, Goldman JM, Apperley JF, Rahemtulla A: Serum levels of macrophage inflammatory protein - 1 alpha (MIP - 1α) correlate with the extent of bone disease and survival in patients with multiple myeloma[J]. Br J Haematol 2003, 123(1):106-109.
4. Hata H: Bone lesions and macrophage inflammatory protein-1 alpha (MIP-1α) in human multiple myeloma[J]. Leuk Lymphoma 2005, 46(7):967-972.
5. Lentzsch S, Chatterjee M, Gries M, Bommert K, Gollasch H, Dorken B, Bargou RC: PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells[J]. Leukemia 2004, 18(11):1883-1890.
6. Lentzsch S, Gries M, Janz M, Bargou R, Dorken B, Mapara MY: Macrophage inflammatory protein 1-alpha (MIP-1α) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells[J]. Blood 2003, 101(9):3568-3573.
7. Heider U, Hofbauer LC, Zavrski I, Kaiser M, Jakob C, Sezer O: Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone disease[J]. Biochem Biophys Res Commun 2005, 338(2):687-693.
8. Han JH, Choi SJ, Kurihara N, Koide M, Oba Y, Roodman GD: Macrophage inflammatory protein-1α is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor κB ligand[J]. Blood 2001, 97(11):3349-3353.
9. Silvestris F, Cafforio P, De Matteo M, Calvani N, Frassanito MA, Dammacco F: Negative regulation of the osteoblast function in multiple myeloma through the repressor gene E4BP4 activated by malignant plasma cells[J]. Clin Cancer Res 2008, 14(19):6081-6091.
10. Silvestris F, Lombardi L, De Matteo M, Bruno A, Dammacco F: Myeloma bone disease: pathogenetic mechanisms and clinical assessment[J]. Leuk Res 2007, 31(2):129-138.
11. Roodman GD: Pathogenesis of myeloma bone disease[J]. Blood Cell Mol Dis 2004, 32(2):290-292.
12. Fu R, Gao S, Peng F, Li J, Liu H, Wang H, Xing L, Shao Z: Relationship between abnormal osteoblasts and cellular immunity in multiple myeloma. Cancer Cell International 2014, 14:62. doi: 10.1186/1475-2867-14-62.
13. Qiang YW, Barlogie B, Rudikoff S, Shaughnessy JD Jr: Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma[J]. Bone 2008, 42(4):669-680.
14. Wang YH, Liu Y, Buhl K, Rowe DW: Comparison of the Action of Transient and Continuous PTH on Primary Osteoblast Cultures Expressing Differentiation Stage-Specific GFP[J]. J Bone Miner Res 2005, 20(1):5-14.
15. Green S, Chambon P: Carcinogenesis: a superfamily of potentially oncogenic hormone receptors[J]. Nature 1986, 324:615-617.
16. Barnes MJ: Function of ascorbic acid in collagen metabolism[J]. Ann N Y Acad Sci 1975, 258(1):264-277.
17. Bellows CG, Aubin JE, Heersche JN, Antosz ME: Mineralized bone nodules formedin vitro from enzymatically released rat calvaria cell populations[J]. Calcif Tissue Int 1986, 38(3):143-154.
18. Anderson RE, Kemp JW, Jee WS, Woodbury DM: Ion-transporting ATPases and matrix mineralization in cultured osteoblastlike cells[J]. In Vitro 1984, 20(11):837-846.
19. Bataille R, Chappard D, Marcelli C, Dessauw P, Sany J, Baldet P, Alexandre C: Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease[J]. J Clin Oncol 1989, 7(12):1909-1914.
20. Silvestris F, Cafforio P, Tucci M, Grinello D, Dammacco F: Upregulation of osteoblast apoptosis by malignant plasma cells: a role in myeloma bone disease[J]. Br J Haematol 2003, 122(1):39-52.
21. Fuller K, Owens JM, Chambers TJ: Macrophage inflammatory protein-1 alpha and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts[J]. J Immunol 1995, 154(11):6065-6072.
22. Kukita T, Nomiyama H, Ohmoto Y, Kukita A, Shuto T, Hotokebuchi T, Sugioka Y, Miura R, Iijima T: Macrophage inflammatory protein-1 alpha (LD78) expressed in human bone marrow: its role in regulation of hematopoiesis and osteoclast recruitment[J]. Laboratory Invest 1997, 76(3):399-406.
23. Tsubaki M, Kato C, Manno M, Ogaki M, Satou T, Itoh T, Kusunoki T, Tanimori Y, Fujiwara K, Matsuoka H, Nishida S: Macrophage inflammatory protein-1α (MIP-1α) enhances a receptor activator of nuclear factor κB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K/Akt pathways[J]. Mol Cell Biochem 2007, 304(1-2):53-60.
24. Olsen BR, Reginato AM, Wang W: Bone development[J]. Annu Rev Cell Dev Biol 2000, 16(1):191-220.
25. Vallet S, Pozzi S, Patel K, Vaghela N, Fulciniti MT, Veiby P, Hideshima T, Santo L, Cirstea D, Scadden DT, Anderson KC, Raje N: A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function[J]. Leukemia 2011, 25(7):1174-1181.
26. Komori T: Regulation of bone development and maintenance by Runx2[J]. Front Biosci: a journal and virtual library 2007, 13:898-903.
27. Nishio Y, Dong Y, Paris M, O'Keefe RJ, Schwarz EM, Drissi H: Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene[J]. Gene 2006, 372:62-70.
28. Gao Y, Jheon A, Nourkeyhani H, Kobayashi H, Ganss B: Molecular cloning, structure, expression, and chromosomal localization of the human Osterix (SP7) gene[J]. Gene 2004, 341:101-110.
29. Hill TP, Später D, Taketo MM, Birchmeier W, Hartmann C: Canonical Wnt/β-catenin signaling prevents osteoblasts from differentiating into chondrocytes[J]. Dev Cell 2005, 8(5):727-738.
30. Glass DA II, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G: Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation[J]. Dev Cell 2005, 8(5):751-764.
31. Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB: Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression[J]. J Biol Chem 2005, 280(39):33132-33140.